ArticleScientific reports2025
Fine tuned CatBoost machine learning approach for early detection of cardiovascular disease through predictive modeling.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- To explore or not: machine learning models for intraoperative decision on testicular exploration in infants under 3 months with incarcerated inguinal hernia.BMC surgery · 2026Article
- Identification and validation of an explainable machine learning model for early postoperative pulmonary complications after esophagectomy in patients with esophageal cancer.Journal of gastrointestinal oncology · 2026Article
- Comparative study of 11 machine learning algorithms for predicting recurrence risk after atrial fibrillation catheter ablation based on a real-world cohort: a retrospective study.BMC cardiovascular disorders · 2026Article
- Predictors of Unfavorable Outcomes in Diabetic Foot Ulcers.Diagnostics (Basel, Switzerland) · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cardiovascular disease (CVD) remains one of the leading causes of morbidity and mortality worldwide, highlighting the urgent need for early-stage diagnosis to improve clinical outcomes. Machine learning (ML) approaches have demonstrated substantial potential in predictive modeling for CVD risk assessment. In this study, we propose an advanced predictive model based on the CatBoost algorithm to classify various stages of CVD using hospital records as the primary data source. The dataset, sourced from a publicly available repository, comprises 12 key predictor variables. The proposed methodology incorporates feature selection, rigorous validation processes, and data augmentation to enhance predictive performance and address the challenges associated with high-dimensional medical data. Among several ML algorithms evaluated, the fine-tuned CatBoost model achieved the highest performance, automating feature selection and facilitating the detection of early-stage heart disease. The model attained an impressive F1-score of 99% and an overall accuracy of 99.02%, outperforming existing ML-based approaches. These findings underscore the potential of the CatBoost algorithm for rapid and accurate CVD diagnosis, thereby supporting clinical decision-making. Future work will focus on external validation and testing on independent datasets to further assess the model's generalizability and clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.